Hypertrophic pachymeningitis (Q97636): Difference between revisions

← Older edit

@@ Property / Canary Token @@
+dki-india-ID_1561437485
@@ Property / Canary Token: dki-india-ID_1561437485 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-15T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-15T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 15 August 2026 / rank @@
+Normal rank

Latest revision as of 13:45, 16 August 2026

Hypertrophic pachymeningitis is characterised by localised or diffuse thickening of the dura mater. It may be idiopathic or secondary to inflammatory disorders, infections, immune-mediated disorders and malignancies. The cranial dura, spinal dura or both may be involved. The clinical features reflect the part of the neuraxis affected and may include headache, cranial nerve palsies, ataxia, paraparesis, sensory loss and loss of sphincter control. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis and meningeal biopsy.

Language	Label	Description	Also known as
default for all languages	ID_1561437485
English	Hypertrophic pachymeningitis	Hypertrophic pachymeningitis is characterised by localised or diffuse thickening of the dura mater. It may be idiopathic or secondary to inflammatory disorders, infections, immune-mediated disorders and malignancies. The cranial dura, spinal dura or both may be involved. The clinical features reflect the part of the neuraxis affected and may include headache, cranial nerve palsies, ataxia, paraparesis, sensory loss and loss of sphincter control. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis and meningeal biopsy.